Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant.
Saved in:
| Title: | Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant. |
|---|---|
| Authors: | Ryan, Kathryn A.1 (AUTHOR) kathryn.ryan@ukhsa.gov.uk, Bewley, Kevin R.1 (AUTHOR), Watson, Robert J.1 (AUTHOR), Burton, Christopher1 (AUTHOR), Carnell, Oliver1 (AUTHOR), Cavell, Breeze E.1 (AUTHOR), Challis, Amy1 (AUTHOR), Coombes, Naomi S.1 (AUTHOR), Davies, Elizabeth R.1 (AUTHOR), Edun-Huges, Jack1 (AUTHOR), Emery, Kirsty1 (AUTHOR), Fell, Rachel1 (AUTHOR), Fotheringham, Susan A.1 (AUTHOR), Gooch, Karen E.1 (AUTHOR), Gowan, Kathryn1 (AUTHOR), Handley, Alastair1 (AUTHOR), Harris, Debbie J.1 (AUTHOR), Hesp, Richard1 (AUTHOR), Hunter, Laura1 (AUTHOR), Humphreys, Richard1 (AUTHOR) |
| Source: | PLoS Pathogens. 4/4/2023, Vol. 18 Issue 4, p1-25. 25p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 15537366 |
|---|---|
| DOI: | 10.1371/journal.ppat.1011293 |